Company profile: Solvotrin Therapeutics
1.1 - Company Overview
Company description
- Provider of pharmaceutical products leveraging a patented prodrug platform to create new chemical entities by combining well-established compounds, focused on cardiovascular applications. Offers iron and folic acid products including Active Iron (14–25mg) and Active Folic (400µg), plus formulations for women and pregnancy with multivitamin and omega-3 support.
Products and services
- Active Iron Advance: Containing 25mg iron, this dose-specific product is engineered to increase iron and energy levels
- Active Iron for Women: Containing 17mg iron plus a multivitamin tablet, this women-specific product supports iron levels and women’s nutritional needs with combined micronutrient support
- Active Iron Pregnancy Plus: Containing 25mg iron plus a multivitamin tablet and omega 3 softgels, this prenatal product provides nutritional support for both mother and baby
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Solvotrin Therapeutics
3i Solutions
HQ: United States
Website
- Description: Provider of solutions that make oil-soluble materials water dispersible.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3i Solutions company profile →
Danisco
HQ: Denmark
Website
- Description: Provider of food ingredients and industrial bioproducts across Europe, North America, Latin America and Asia Pacific, including food emulsifiers and GRINDSTED SOFT-N-SAFE vegetable-based plasticizer. Offers Nourish for innovative food and beverage experiences; Health & Biosciences using bioscience, microbiome and fermentation; Scent crafting fragrance experiences; and Pharma Solutions with ingredients and delivery technologies for pharmaceuticals and dietary supplements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Danisco company profile →
Prenexus Health
HQ: United States
Website
- Description: Provider of prebiotic ingredients as a manufacturer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prenexus Health company profile →
NattoPharma
HQ: Norway
Website
- Description: Provider of nutritional yeasts, probiotics, and active ingredients for dietary supplements, functional foods, beverages, and pharmaceuticals. Collaborates with brands to develop products including Quatrefolic, Lynside S. boulardii, and LANDKIND Pure Salidroside to support health benefits. Online inquiry form available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NattoPharma company profile →
NutriLeads
HQ: The Netherlands
Website
- Description: Provider of plant-based precision prebiotic fibers and nutritional ingredients with demonstrated health effects. Partners with food industry companies to identify promising lead ingredients and develop sustainable, commercially viable production processes. Offers Benicaros, a precision prebiotic fiber from upcycled carrot pomace designed to enhance immune responses and improve gut microbiota composition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NutriLeads company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Solvotrin Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Solvotrin Therapeutics
2.2 - Growth funds investing in similar companies to Solvotrin Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Solvotrin Therapeutics
4.2 - Public trading comparable groups for Solvotrin Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →